Ringdén O - Search Results

1

Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua.

Moll G, Ignatowicz L, Catar R, Luecht C, Sadeghi B, Hamad O, Jungebluth P, Dragun D, Schmidtchen A, Ringdén O. Moll G, et al. Among authors: ringden o. Stem Cells Dev. 2015 Oct 1;24(19):2269-79. doi: 10.1089/scd.2015.0120. Epub 2015 Aug 24. Stem Cells Dev. 2015. PMID: 26192403

2

Serum IgE levels after bone marrow transplantation.

Abedi MR, Bäckman L, Persson U, Ringdén O. Abedi MR, et al. Among authors: ringden o. Bone Marrow Transplant. 1989 May;4(3):255-60. Bone Marrow Transplant. 1989. PMID: 2659111

3

Allogeneic bone marrow transplantation in 24 patients with multiple myeloma reported to the EBMT registry.

Gahrton G, Tura S, Flesch M, Gratwohl A, Gravett P, Lindeberg A, Lucarelli G, Michallet M, Reiffers J, Ringdén O, et al. Gahrton G, et al. Among authors: ringden o. Hematol Oncol. 1988 Apr-Jun;6(2):181-6. doi: 10.1002/hon.2900060219. Hematol Oncol. 1988. PMID: 3292376

4

Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients.

Ljungman P, Johansson N, Aschan J, Glaumann H, Lönnqvist B, Ringdén O, Sparrelid E, Sönnerborg A, Winiarski J, Gahrton G. Ljungman P, et al. Among authors: ringden o. Blood. 1995 Aug 15;86(4):1614-8. Blood. 1995. PMID: 7632971 Free article.

5

Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation.

Ljungman P, Lewensohn-Fuchs I, Hammarström V, Aschan J, Brandt L, Bolme P, Lönnqvist B, Johansson N, Ringdén O, Gahrton G. Ljungman P, et al. Among authors: ringden o. Blood. 1994 Jul 15;84(2):657-63. Blood. 1994. PMID: 8025290 Free article.

6

Bone marrow transplantation using unrelated donors for haematological malignancies.

Ringdén O. Ringdén O. Med Oncol. 1997 Mar;14(1):11-22. doi: 10.1007/BF02990940. Med Oncol. 1997. PMID: 9232606 Review.

7

Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver.

Remberger M, Ringdén O. Remberger M, et al. Among authors: ringden o. Eur J Haematol. 1997 Oct;59(4):254-62. doi: 10.1111/j.1600-0609.1997.tb00985.x. Eur J Haematol. 1997. PMID: 9338624

8

Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation.

Remberger M, Ringdén O, Ljungman P, Hägglund H, Winiarski J, Lönnqvist B, Aschan J. Remberger M, et al. Among authors: ringden o. Bone Marrow Transplant. 1998 Jul;22(1):73-8. doi: 10.1038/sj.bmt.1701290. Bone Marrow Transplant. 1998. PMID: 9678799

9

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.

Le Blanc K, Ringdén O. Le Blanc K, et al. Among authors: ringden o. Biol Blood Marrow Transplant. 2005 May;11(5):321-34. doi: 10.1016/j.bbmt.2005.01.005. Biol Blood Marrow Transplant. 2005. PMID: 15846285 Free article. Review.

10

Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.

Ringdén O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lönnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K. Ringdén O, et al. Transplantation. 2006 May 27;81(10):1390-7. doi: 10.1097/01.tp.0000214462.63943.14. Transplantation. 2006. PMID: 16732175 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

766 results

Search Page

Filters